{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:32:36Z","timestamp":1792762356011,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00431-021-04301-x","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T07:02:31Z","timestamp":1636009351000},"page":"1269-1275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Enhanced INSURE (ENSURE): an updated and standardised reference for surfactant administration"],"prefix":"10.1007","volume":"181","author":[{"given":"Feriel","family":"Fortas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Loi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Centorrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Regiroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafik","family":"Ben-Ammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Shankar-Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadya","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3846-4834","authenticated-orcid":false,"given":"Daniele","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"4301_CR1","first-page":"2139","volume":"154","author":"H Verder","year":"1992","unstructured":"Verder H, Agertoft L, Albertsen P, Christensen N, Curstedt T, Ebbesen F et al (1992) Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study Ugeskr Laeger 154:2139\u20132139","journal-title":"A pilot study Ugeskr Laeger"},{"issue":"4","key":"4301_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/children8040261","volume":"8","author":"P Patel","year":"2021","unstructured":"Patel P, Houck A, Fuentes D (2021) Examining Variations in Surfactant Administration (ENVISION): a neonatology insights pilot project. Children 8(4):261. https:\/\/doi.org\/10.3390\/children8040261","journal-title":"Children"},{"key":"4301_CR3","doi-asserted-by":"publisher","unstructured":"Abdel-Latif ME, Davis PG, Wheeler KI, De Paoli AG, Dargaville PA (2021) Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev 5(5):CD011672.\u00a0https:\/\/doi.org\/10.1002\/14651858.CD011672.pub2","DOI":"10.1002\/14651858.CD011672.pub2"},{"issue":"4","key":"4301_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S2352-4642(19)30405-5","volume":"4","author":"D De Luca","year":"2020","unstructured":"De Luca D, Shankar-Aguilera S, Centorrino R, Fortas F, Yousef N, Carnielli VP (2020) Less invasive surfactant administration: a word of caution. Lancet Child Adolesc Health 4(4):331\u2013340. https:\/\/doi.org\/10.1016\/S2352-4642(19)30405-5","journal-title":"Lancet Child Adolesc Health"},{"issue":"2","key":"4301_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2021.101230","volume":"26","author":"D De Luca","year":"2021","unstructured":"De Luca D, Shankar-Aguilera S, Bancalari E (2021) LISA\/MIST: Complex clinical problems almost never have easy solutions. Semin Fetal Neonatal Med 26(2):101230. https:\/\/doi.org\/10.1016\/j.siny.2021.101230","journal-title":"Semin Fetal Neonatal Med"},{"issue":"4","key":"4301_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.siny.2016.03.004","volume":"21","author":"S Vijayasekaran","year":"2016","unstructured":"Vijayasekaran S, Lioy J, Maschhoff K (2016) Airway disorders of the fetus and neonate: an overview. Semin Fetal Neonatal Med 21(4):220\u2013229. https:\/\/doi.org\/10.1016\/j.siny.2016.03.004","journal-title":"Semin Fetal Neonatal Med"},{"key":"4301_CR7","unstructured":"Moureau R, Yousef N, Poteaux N, De Luca D (2021) Am\u00e9lioration de la qualit\u00e9 des soins et gestion des risques par la simulation in situ en r\u00e9animation n\u00e9onatale [Quality improvement and risk management using in situ simulation in neonatal intensive care units]. Proceedings of the SoFraSIMS congress Paris [abstract]"},{"key":"4301_CR8","doi-asserted-by":"publisher","unstructured":"Topjian AA, Raymond TT, Atkins D, Chan M, Duff JP, Joyner BL et al (2020) Part 4: Pediatric Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 142(16 suppl 2). https:\/\/doi.org\/10.1161\/CIR.0000000000000901","DOI":"10.1161\/CIR.0000000000000901"},{"key":"4301_CR9","doi-asserted-by":"crossref","unstructured":"Smits A, Thewissen L, Caicedo A, Naulaers G, Allegaert K (2016) Propofol dose-finding to reach optimal effect for (semi-)elective intubation in neonates. J Pediatr 179:54\u201360.e9","DOI":"10.1016\/j.jpeds.2016.07.049"},{"key":"4301_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41390-018-0160-3","volume":"84","author":"L Thewissen","year":"2018","unstructured":"Thewissen L, Caicedo A, Dereymaeker A, Van Huffel S, Naulaers G, Allegaert K et al (2018) Cerebral autoregulation and activity after propofol for endotracheal intubation in preterm neonates. Pediatr Res 84:719\u2013725. https:\/\/doi.org\/10.1038\/s41390-018-0160-3","journal-title":"Pediatr Res"},{"issue":"1","key":"4301_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13054-020-2787-9","volume":"24","author":"Y Singh","year":"2020","unstructured":"Singh Y, Tissot C, Fraga MV, Yousef N, Cortes RG, Lopez J et al (2020) International evidence-based guidelines on Point of Care Ultrasound (POCUS) for critically ill neonates and children issued by the POCUS Working Group of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC). Crit Care 24(1):65. https:\/\/doi.org\/10.1186\/s13054-020-2787-9","journal-title":"Crit Care"},{"key":"4301_CR12","doi-asserted-by":"publisher","unstructured":"Spence K, Barr P (2000) Nasal versus oral intubation for mechanical ventilation of newborn infants. Cochrane Database Syst Rev 1999(2):CD000948.\u00a0https:\/\/doi.org\/10.1002\/14651858.CD000948","DOI":"10.1002\/14651858.CD000948"},{"key":"4301_CR13","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000499361","volume":"115","author":"DG Sweet","year":"2019","unstructured":"Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, te Pas A et al (2019) European Consensus guidelines on the management of respiratory distress syndrome \u2013 2019 update. Neonatology 115:432\u2013450","journal-title":"Neonatology"},{"key":"4301_CR14","doi-asserted-by":"publisher","unstructured":"Klingenberg C, Wheeler KI, McCallion N, Morley CJ, Davis PG (2017) Volume-targeted versus pressure-limited ventilation in neonates. Cochrane Database Syst Rev 10(10):CD003666.\u00a0https:\/\/doi.org\/10.1002\/14651858.CD003666.pub4.","DOI":"10.1002\/14651858.CD003666.pub4"},{"key":"4301_CR15","doi-asserted-by":"publisher","unstructured":"Lemyre B, Davis PG, De Paoli AG, Kirpalani H (2017) Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. Cochrane Database Syst Rev 2(2):CD003212. https:\/\/doi.org\/10.1002\/14651858.CD003212.pub3.","DOI":"10.1002\/14651858.CD003212.pub3"},{"key":"4301_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jpeds.2019.04.020","volume":"212","author":"R Raschetti","year":"2019","unstructured":"Raschetti R, Yousef N, Vigo G, Marseglia G, Centorrino R, Ben-Ammar R et al (2019) Echography-guided surfactant therapy to improve timeliness of surfactant replacement: a quality improvement project. J Pediatr 212:137-143.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2019.04.020","journal-title":"J Pediatr"},{"key":"4301_CR17","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.chest.2019.11.013","volume":"157","author":"C Gomond-LeGoff","year":"2020","unstructured":"Gomond-LeGoff C, Vivalda L, Foligno S, Loi B, Yousef N, De Luca D (2020) Effect of different probes and expertise on the interpretation reliability of point-of-care lung ultrasound. Chest 157:924\u2013931. https:\/\/doi.org\/10.1016\/j.chest.2019.11.013","journal-title":"Chest"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-04301-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-021-04301-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-04301-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:57:58Z","timestamp":1744192678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-021-04301-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["4301"],"URL":"https:\/\/doi.org\/10.1007\/s00431-021-04301-x","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,4]]},"assertion":[{"value":"19 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved by the \u201cCommission d\u2019Ethique de la SRLF\u201d\u2014n.21\/33.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Obtained from parents or guardian upon NICU admission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Obtained from parents of the recorded neonate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Prof. De Luca has received research and educational grants from Chiesi Pharmaceuticals S.p.A. and ABBVIE Inc. He served as lecturer for Airway Therapeutics, Chiesi Pharmaceuticals S.p.A. and ABBVIE Inc. Finally, he has been member of advisory boards for Chiesi Pharmaceuticals S.p.A., ABBVIE Inc. and OPHIREX Inc. He is titular of an equity option of OPHIREX Inc. Dr. Shankar-Aguilera and Yousef received a travel grant from Chiesi Pharmaceuticals S.p.A.. These companies produce surfactants or surfactant proteins, but had no role in design, preparation, review, approval of the manuscript, or decision to submit it for publication. The declared conflicts are all unrelated to the present manuscript. The other authors have no conflicts of interest to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}